#HIT #AI
Disease, Health care, Medicine, Infectious disease, Infection, Epidemiology

The 2020 Disruptive Dozen

On Jun 2, 2020
@evankirstel shared
RT @DrHugue: Top 12 Disruptive Healthcare Technologies. ⁦@JimBrinkMD⁩ ⁦@BredellaMD⁩ ⁦@evankirstel⁩ ⁦@DrIanWeissman⁩ ⁦@Vilavaite⁩ ⁦@MargaretSiegien⁩ ⁦@CurieuxExplorer⁩ ⁦@Nicochan33⁩ ⁦⁦@Dahl_Consult⁩ ⁦#AI #HIT https://t.co/fe4rS1ZyzV
Open

TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual “Disruptive Dozen,” the 12 emerging clinical and artificial intelligence technologies with the ...

innovationblog.partners.org
On Jun 2, 2020
@evankirstel shared
RT @DrHugue: Top 12 Disruptive Healthcare Technologies. ⁦@JimBrinkMD⁩ ⁦@BredellaMD⁩ ⁦@evankirstel⁩ ⁦@DrIanWeissman⁩ ⁦@Vilavaite⁩ ⁦@MargaretSiegien⁩ ⁦@CurieuxExplorer⁩ ⁦@Nicochan33⁩ ⁦⁦@Dahl_Consult⁩ ⁦#AI #HIT https://t.co/fe4rS1ZyzV
Open

The 2020 Disruptive Dozen

The 2020 Disruptive Dozen

TOP 12 DISRUPTIVE HEALTHCARE TECHNOLOGIES Mapping spread of infectious diseases and reducing health disparities top list Mass General Brigham announced its selections for the sixth annual ...

LBA-5 Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

LBA-5 Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Program: General Sessions Session: Late-Breaking Abstracts Session Hematology Disease Topics & Pathways: Biological, sickle cell disease, Diseases, Therapies, Hemoglobinopathies, gene ...

How Machine Learning Is Shaping The Future Of Precision Medicine

How Machine Learning Is Shaping The Future Of Precision Medicine

The precision medicine market is transforming massively as machine learning steps in to help shape the future of drug design.

How the Greater Boston biomedical community is tackling the coronavirus

How the Greater Boston biomedical community is tackling the coronavirus

At a historic meeting held Monday at Harvard Medical School, more than 80 clinicians and scientists came together to commit to a response.

COVID test debacle: ‘We hoped it would go away before it reached us’

COVID test debacle: ‘We hoped it would go away before it reached us’

Massachusetts may need 1.4 million COVID-19 tests and ramp up to tens of thousands given a day, Harvard experts said.

My message to America’s top scientists

My message to America’s top scientists

AI and genetics can benefit the world’s poorest—if we make the effort.

Why We Need More Hispanic and Latino STEMists: Q&A with José Trevejo, M.D., Ph.D.

Why We Need More Hispanic and Latino STEMists: Q&A with José Trevejo, M.D., Ph.D.

I would like to think that being part of la raza cósmica, represents the bringing together of a great diversity of ethnicities and cultures into a rich tapestry that will take us toward ...

The Wyss Institute’s response to COVID-19: beating back the coronavirus

The Wyss Institute’s response to COVID-19: beating back the coronavirus

Wyss Institute researchers are confronting the coronavirus crisis on all fronts – by rapidly developing much needed diagnostic and therapeutic inventions

The Future of Medicine

The Future of Medicine

As part of the celebration of Lawrence Bacow’s inauguration as Harvard University’s 29th president, six world-renowned life scientists from across the university came together to discuss ...

REVOLUTIONIZING DRUG DEVELOPMENT WITH NEW DISEASE MODELS AND SIMULATION METHODS: CASE STUDIES OF COLLABORATIVE GLOBAL EFFORTS

REVOLUTIONIZING DRUG DEVELOPMENT WITH NEW DISEASE MODELS AND SIMULATION METHODS: CASE STUDIES OF COLLABORATIVE GLOBAL EFFORTS

12:00 pm Advanced Bioinformatics Techniques for Biologics Drug Discovery Andrew LeBeau, PhD, Associate Vice President, Biologics, Marketing, Dotmatics Biologics drug discovery requires ...

How AI could shape the health tech landscape in 2019

How AI could shape the health tech landscape in 2019

Highlights include technologies that cut costs and promote patient health, especially in the areas of imaging diagnostic, predictive analytics and administration.